Non Animal Testing Database

Biochemical diagnosis of Parkinson's disease

December 2016
The University of Texas School of Medicine at Houston, Houston, USA
Parkinson's disease is a devastating neurodegenerative disorder characterized by a massive dopaminergic loss that leads to motor and cognitive decline and, ultimately, death. Despite its high prevalence, there is a lack of diagnostic tools that allow a non-invasive biochemical evaluation to help in the early diagnosis and monitoring of the disease. One of the main pathological processes in Parkinson's disease is the accumulation of alpha-synuclein aggregates, which can be detected in small quantities in patients' cerebrospinal fluid. Here, a protein misfolding cyclic amplification is used to detect minimum amounts of alpha-synuclein aggregates, through a strategy of signal amplification. After the first validation with synthetic oligomers in vitro, this technique allowed for the identification of 88.5% of Parkinson's disease patients, with a specificity of 96.9% when using samples of patients with different neurodegenerative disorders. Additionally, the results of this test highly correlated with the severity of the disease. Here, the researchers propose a new non-invasive diagnostic approach to efficiently identify and discriminate Parkinson's patients, with a potential use in monitoring of the disease.
Development of a biochemical diagnosis of Parkinson disease by detection of α-synuclein misfolded aggregates in cerebrospinal fluid
Claudio Soto
Added on: 09-04-2021
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!